This study aims to identify potential antimalarials from Food and Drug Administration (FDA) approved drugs
The hemoglobin degradation process in Plasmodium parasites is vital for nutrient acquisition require...
Malaria is a parasitic tropical disease that kills around 600,000 patients every year. The emergence...
Objective: Docking studies of aminohydantoin derivatives as antimalarial agents. A novel derivative ...
This study aims to identify potential antimalarials from Food and Drug Administration (FDA) approved...
Malaria elimination can benefit from time and cost-efficient approaches for antimalarials such as dr...
Background: The critically important issue on emergence of drug-resistant malarial parasites is comp...
Malaria continues to be a global health threat, with approximately 247 million cases worldwide. Desp...
Malaria is an infectious disease that affects over 216 million people worldwide, killing over 445,00...
Compared to the previous year, there has been an increase of nearly 2 million malaria cases in 2021....
The growing resistance to current first-line antimalarial drugs represents a major health challenge....
In this study, we intended to find potential 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) i...
The main challenge in the control of malaria has been the emergence of drug-resistant parasites. The...
Malaria is a millennia-old disease with the first recorded cases dating back to 2700 BC found in Chi...
Malaria is an infectious disease caused by a diverse group of erythrocytic protozoan parasites of th...
Quantitative structure–activity relationship (QSAR) models have been developed for a dataset of 3133...
The hemoglobin degradation process in Plasmodium parasites is vital for nutrient acquisition require...
Malaria is a parasitic tropical disease that kills around 600,000 patients every year. The emergence...
Objective: Docking studies of aminohydantoin derivatives as antimalarial agents. A novel derivative ...
This study aims to identify potential antimalarials from Food and Drug Administration (FDA) approved...
Malaria elimination can benefit from time and cost-efficient approaches for antimalarials such as dr...
Background: The critically important issue on emergence of drug-resistant malarial parasites is comp...
Malaria continues to be a global health threat, with approximately 247 million cases worldwide. Desp...
Malaria is an infectious disease that affects over 216 million people worldwide, killing over 445,00...
Compared to the previous year, there has been an increase of nearly 2 million malaria cases in 2021....
The growing resistance to current first-line antimalarial drugs represents a major health challenge....
In this study, we intended to find potential 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) i...
The main challenge in the control of malaria has been the emergence of drug-resistant parasites. The...
Malaria is a millennia-old disease with the first recorded cases dating back to 2700 BC found in Chi...
Malaria is an infectious disease caused by a diverse group of erythrocytic protozoan parasites of th...
Quantitative structure–activity relationship (QSAR) models have been developed for a dataset of 3133...
The hemoglobin degradation process in Plasmodium parasites is vital for nutrient acquisition require...
Malaria is a parasitic tropical disease that kills around 600,000 patients every year. The emergence...
Objective: Docking studies of aminohydantoin derivatives as antimalarial agents. A novel derivative ...
DOI
Add to ORKG